The present invention concerns a new use for a composition comprising chloroprocaine HCI and in particular its use for the manufacture of a drug for intrathecal narcosis. The present invention also concerns a new composition comprising chloroprocaine HCI being particularly suited to this new use as well as a new method for manufacturing said composition.

The present invention concerns a new use for a composition comprising chloroprocaine HCl and in particular its use for the manufacture of a drug for intrathecal narcosis. The present invention also concerns a new composition comprising chloroprocaine HCl being particularly suited to this new use as well as a new method for manufacturing said composition.

SARS Ebola Marburg West Nile German Measles Yellow Fever Saint Louis Encephalitis Japanese Encephalitis California Encephalitis Human T-cell Leukemia Newcastle Disease respiratory tract infection and bronchitis Lymphocytic Choriomeningitis Lassa Hemorrhagic Fever and Hanta Hemorrhagic Fever are treated by IM injection of a mixture comprising a first ingredient selected from the group consisting of procaine chloroprocaine tetracaine chlorotetracaine bromoprocaine proparacaine fluoroprocaine and b...

Aerosol compositions used for anesthetizing mammals in both human and veterinary applications include prilocaine base solubilized in the hydrofluorocarbon (HFC) propellants 1112-tetrafluoroethane and 1112333-heptafluoropropane. Prilocaine base has been found to be readily soluble in HFC propellants when combined in liquid or micro rod form and a solution stable to temperatures as low as -82 DEG C. is formed upon combination of the two components. In the aerosol compositions the HFCs are the onl...